MYC and B-cell non-Hodgkin lymphoma: Objective responses were seen across DLBCL subtypes, including activated B cell, germinal center B cell and high-grade B cell lymphoma double hit (HGBL-DH, with MYC and BCL2 rearrangements) subtypes.